Taysha Gene Therapies

Suyash Prasad, Chief Medical Officer and Head of Research and Development

Oct. 12 | 2:30pm | AVROBIO Ballroom

Dallas, TX

(NASDAQ: TSHA)

In-person Presentation

Taysha Gene Therapies is on a mission to eradicate monogenic central nervous system disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform – an engine for potential new cures – with a goal of dramatically improving patients’ lives. 

www.tayshagtx.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions